Project title: NETcure—shine new light on neuroendocrine tumor therapy
Martin Gotthardt, PhD Radboud University, Netherlands
- Status: Active
- Year(s): 2019
- Grant Type: Investigator
- Research Type: Clinical
- Area of Inquiry: Diagnostic
- Also seen in March 2021 eUpdate
An international collaboration in Spain and the Netherlands will explore photodynamic therapy. The team will develop a “photosensitizer,” which is a molecule that upon activation with light induces cell death. The photosensitizer will be coupled to peptides that bind to NET cells and tested for its ability to kill them.
- City: Nijmegen
- Grant Duration: 2 years
NETRF funds laboratory research to understand the development of neuroendocrine tumors and translational research to explore new concepts in treatment. Research grant descriptions and research updates from NETRF are not intended to serve as medical advice. It can take years for research discoveries to be fully validated and approved for patient care. Always consult your health care providers about your treatment options.